Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection

Ítems similars

• Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
  per: Tai, Wanbo, et al.
  Publicat: (2020)
• Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
  per: Du, Lanying, et al.
  Publicat: (2008)
• Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
  per: Du, Lanying, et al.
  Publicat: (2009)
• Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine
  per: He, Yuxian, et al.
  Publicat: (2006)
• The spike protein of SARS-CoV — a target for vaccine and therapeutic development
  per: Du, Lanying, et al.
  Publicat: (2009)